These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 12203035

  • 1. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
    Costa AM, Lemos-Marini SH, Baptista MT, Morcillo AM, Maciel-Guerra AT, Guerra G.
    J Bone Miner Metab; 2002; 20(5):294-7. PubMed ID: 12203035
    [Abstract] [Full Text] [Related]

  • 2. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z, Cetinkaya E, Darendeliler F, Vidinlisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Bundak R.
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [Abstract] [Full Text] [Related]

  • 3. Turner syndrome and osteoporosis: mechanisms and prognosis.
    Rubin K.
    Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients.
    Carrascosa A, Gussinyé M, Terradas P, Yeste D, Audí L, Vicens-Calvet E.
    J Bone Miner Res; 2000 Oct; 15(10):2005-10. PubMed ID: 11028454
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
    Strandberg S, Nordström P, Lorentzon R, Lorentzon M.
    J Bone Miner Metab; 2003 Oct; 21(2):109-13. PubMed ID: 12601576
    [Abstract] [Full Text] [Related]

  • 6. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry.
    Högler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):193-9. PubMed ID: 14715849
    [Abstract] [Full Text] [Related]

  • 7. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome.
    El-Mansoury M, Barrenäs ML, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen K.
    Clin Endocrinol (Oxf); 2007 May; 66(5):744-51. PubMed ID: 17381484
    [Abstract] [Full Text] [Related]

  • 8. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome.
    Han TS, Cadge B, Conway GS.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):643-7. PubMed ID: 17054467
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density and correlation factor analysis in normal Taiwanese children.
    Shu SG.
    Acta Paediatr Taiwan; 2007 Nov; 48(6):323-7. PubMed ID: 18437966
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M, Sarihan H, Madenci E.
    J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
    [Abstract] [Full Text] [Related]

  • 11. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
    Kosowicz J, El Ali Z, Ziemnicka K, Sowinski J.
    J Clin Densitom; 2007 Feb; 10(3):332-9. PubMed ID: 17470407
    [Abstract] [Full Text] [Related]

  • 12. Treatment outcome in Turner syndrome.
    Parvin M, Roche E, Costigan C, Hoey HM.
    Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, Sebag G, Vilmer E, Léger J.
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [Abstract] [Full Text] [Related]

  • 18. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K, Konstantynowicz J, Krawczuk-Rybak M.
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [Abstract] [Full Text] [Related]

  • 19. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome.
    Bannink EM, Raat H, Mulder PG, de Muinck Keizer-Schrama SM.
    J Pediatr; 2006 Jan; 148(1):95-101. PubMed ID: 16423606
    [Abstract] [Full Text] [Related]

  • 20. The relationship between lean body mass and bone mineral content in paediatric health and disease.
    Crabtree NJ, Kibirige MS, Fordham JN, Banks LM, Muntoni F, Chinn D, Boivin CM, Shaw NJ.
    Bone; 2004 Oct; 35(4):965-72. PubMed ID: 15454104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.